GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » Additional Paid-In Capital

Universal Ibogaine (TSXV:IBO) Additional Paid-In Capital : C$4.07 Mil(As of Apr. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Universal Ibogaine Additional Paid-In Capital?


Universal Ibogaine's quarterly additional paid-in capital increased from Oct. 2023 (C$4.05 Mil) to Jan. 2024 (C$4.06 Mil) and increased from Jan. 2024 (C$4.06 Mil) to Apr. 2024 (C$4.07 Mil).

Universal Ibogaine's annual additional paid-in capital increased from Mar. 2021 (C$0.12 Mil) to Jul. 2022 (C$3.88 Mil) and increased from Jul. 2022 (C$3.88 Mil) to Jul. 2023 (C$4.04 Mil).

Universal Ibogaine Additional Paid-In Capital Historical Data

The historical data trend for Universal Ibogaine's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine Additional Paid-In Capital Chart

Universal Ibogaine Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Jul22 Jul23
Additional Paid-In Capital
Get a 7-Day Free Trial 0.11 0.10 0.12 3.88 4.04

Universal Ibogaine Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 4.04 4.05 4.06 4.07

Universal Ibogaine Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Universal Ibogaine Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Universal Ibogaine Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » Additional Paid-In Capital
Comparable Companies
XCNQ:NIRV TSXV:WAVE TSXV:SVS TSXV:VXL TSXV:PSYB XCNQ:CURE XCNQ:CMND TSX:IPCI XCNQ:AGN TSXV:MRVL OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
IBOGF:USA JC4:Germany
Address
815 8th Avenue South West, Suite 600, Calgary, AB, CAN, T2P 3P2
Website
https://www.universalibogaine.com
Universal Ibogaine Inc develops a platform of addiction treatment clinics, which use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. It runs addiction clinics it has a research partner clinic in Mexico.
Executives
Ian Rabb Senior Officer

Universal Ibogaine Headlines

From GuruFocus

DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value

By Marketwired • 09-16-2024